Neuropharmacology is a specialized field that explores the interactions between drugs and the nervous system, delving into pharmacodynamics to understand how drugs exert their effects on the intricate neural networks. This branch of pharmacology investigates the mechanisms by which drugs alter cellular and molecular processes within the nervous system, influencing neurotransmitter systems, receptors, and signal transduction pathways. Pharmacodynamics in neuropharmacology involves studying the drug-receptor interactions, elucidating how drugs modulate neuronal activity, and deciphering the impact on synaptic transmission. Whether enhancing or inhibiting neurotransmitter release, altering receptor sensitivity, or affecting ion channel function, pharmacodynamics plays a pivotal role in shaping the pharmacological responses observed in the nervous system. The study of pharmacodynamics in neuropharmacology extends beyond the individual drug level, examining dose-response relationships, therapeutic indices, and the temporal aspects of drug action. Insights gained from pharmacodynamic studies contribute to the development of more targeted and effective neuropharmaceutical interventions, providing a foundation for advancing treatments in neurological and psychiatric disorders.
The intricate interplay between drugs and the nervous system underscores the importance of pharmacodynamics in shaping therapeutic outcomes. Researchers in neuropharmacology continually strive to unravel these complexities, fostering the development of innovative drugs with enhanced efficacy and reduced adverse effects for various neurological conditions.
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Analytical strategies for solid-state forms in drug development
Maria Cristina Gamberini, University of Modena e Reggio Emilia, Italy
Title : Understanding drug transport in plasma: The role of protein binding
Saad Tayyab, UCSI University, Malaysia
Title : Innovative development and delivery of biologics for chronic obstructive pulmonary disease
Yong Xiao Wang, Albany Medical College, United States
Title : Search for novel biomarkers and therapeutic targets for inflammatory disease
Madhav Bhatia, University of Otago, New Zealand
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through de-sign-inspired biotech- & biopharma-driven applications and upgraded business mar-keting to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Design and evaluation of exo-itc: A bilayer fibrous system for controlled exosome delivery in dermatological applications
Luis Jesus Villarreal Gomez, FCITEC - Universidad AutĂłnoma de Baja California, Mexico
Title : Abuse-deterrent dosage form technique utilizing a fusion of innovative pharmaceuticals and ion exchange resin
Bhupendra Gopalbhai Prajapati, Parul University, India
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia